PSC
NXTM

Piper Sandler & Co’s NxStage Medical Inc. NXTM Stock Holding History

Piper Sandler & Co’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-32,200
Closed -$423K – 177
2014
Q3 		$423K Buy
+32,200
New +$434K 0.22% 43
2014
Q1 		– Sell
-5,000
Closed -$50K – 134
2013
Q4 		$50K Buy
+5,000
New +$56.8K 0.04% 88

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's NXTM Position: Q4 2014 in Review

Piper Sandler & Co sold out of NxStage Medical Inc. (NXTM) in Q4 2014, closing a stake of 32,200 shares — an estimated $423K sold.

Piper Sandler & Co first reported a position in NXTM in Q4 2013 and held it in 2 quarters. The position peaked at $423K in Q3 2014. 118 funds tracked by Wall St. Rank hold NXTM as of Q4 2014.

  • Piper Sandler & Co reported no remaining NxStage Medical Inc. position as of Q4 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 32,200 NxStage Medical Inc. shares in Q4 2014, an estimated $423K.
  • Piper Sandler & Co first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 2 quarters.
  • Piper Sandler & Co's NxStage Medical Inc. position peaked at $423K in Q3 2014.
  • 118 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2014.

Based on Piper Sandler & Co's 13F filing for Q4 2014, filed 17 Feb 2015.